GeneDx Holdings Corp. (WGS): Operating Cash Flow
$33.28M
Year ended 2025-12-31
-$48.71M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $33.28M | n/m | 2026-02-23, From 2025-01-01 |
| 2024-12-31 | -$28.50M | n/m | 2026-02-23, From 2024-01-01 |
| 2023-12-31 | -$180.15M | n/m | 2026-02-23, From 2023-01-01 |
| 2022-12-31 | -$319.15M | n/m | 2024-02-23, From 2022-01-01 |
| 2021-12-31 | -$190.43M | n/m | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | -$93.13M | n/m | 2023-03-16, From 2020-01-01 |
| 2019-12-31 | -$18.73M | n/a | 2022-03-14, From 2019-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | 2025-12-31 | $33.28M | n/m |
| DocGo Inc. (DCGO) | 2025-12-31 | $34.45M | -50.9% |
| Omada Health, Inc. (OMDA) | 2025-12-31 | $18.25M | n/m |
| U S Physical Therapy Inc (USPH) | 2025-12-31 | $75.06M | +0.2% |
| Strata Critical Medical, Inc. (SRTA) | 2025-12-31 | -$48.91M | n/m |
| Pennant Group, Inc. (PNTG) | 2025-12-31 | $48.29M | +22.9% |
| InnovAge Holding Corp. (INNV) | 2026-06-30 | $64.71M | +96.9% |
| LifeStance Health Group, Inc. (LFST) | 2025-12-31 | $146.15M | +36.3% |
| P3 Health Partners Inc. (PIII) | 2025-12-31 | -$91.24M | n/m |
Compare WGS, DCGO, OMDA, USPH side by side · Screen every company in Services-Health Services ↗